Association between Retinal Vein Occlusion and Epiretinal Membrane Development - PubMed
5 hours ago
- #Epiretinal Membrane
- #Anti-VEGF
- #Retinal Vein Occlusion
- Study evaluates the association between retinal vein occlusion (RVO) and epiretinal membrane (ERM) development.
- Retrospective cohort study with 19,172 BRVO and 14,974 CRVO patients compared to matched controls.
- Highest risk for ERM formation at three months post-RVO (BRVO: RR=4.54; CRVO: RR=4.90).
- ERM peel risk peaks at one year for BRVO (RR=3.83) and three years for CRVO (RR=3.91).
- Anti-VEGF treatment linked to higher ERM rates at three months (BRVO-T: RR=5.60; CRVO-T: RR=6.80).
- ERM peel incidence in treated eyes peaks at five years (BRVO-T: RR=3.30; CRVO-T: RR=2.60).
- ERM formation typically occurs within first three months post-RVO; surgical intervention peaks later.
- Treated patients show elevated ERM risk, possibly due to baseline disease severity rather than treatment effect.